CVS Health Corporation $CVS Stock Holdings Decreased by Russell Investments Group Ltd.

Russell Investments Group Ltd. lessened its position in shares of CVS Health Corporation (NYSE:CVS) by 18.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,467,318 shares of the pharmacy operator’s stock after selling 554,974 shares during the period. Russell Investments Group Ltd.’s holdings in CVS Health were worth $211,689,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. grew its stake in CVS Health by 256.6% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 322,035 shares of the pharmacy operator’s stock valued at $27,631,000 after acquiring an additional 231,740 shares during the last quarter. Werba Rubin Papier Wealth Management lifted its holdings in shares of CVS Health by 10.9% in the third quarter. Werba Rubin Papier Wealth Management now owns 3,427 shares of the pharmacy operator’s stock valued at $294,000 after purchasing an additional 337 shares in the last quarter. Endeavor Private Wealth Inc. grew its position in shares of CVS Health by 13.9% in the third quarter. Endeavor Private Wealth Inc. now owns 3,642 shares of the pharmacy operator’s stock valued at $312,000 after purchasing an additional 445 shares during the last quarter. Maryland State Retirement & Pension System grew its position in shares of CVS Health by 14.9% in the third quarter. Maryland State Retirement & Pension System now owns 78,768 shares of the pharmacy operator’s stock valued at $6,750,000 after purchasing an additional 10,199 shares during the last quarter. Finally, Ritholtz Wealth Management increased its stake in shares of CVS Health by 7.6% during the 3rd quarter. Ritholtz Wealth Management now owns 27,787 shares of the pharmacy operator’s stock worth $2,381,000 after purchasing an additional 1,967 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CVS. Jefferies Financial Group restated a “buy” rating and set a $103.00 price objective on shares of CVS Health in a research report on Wednesday, November 4th. UBS Group lowered their target price on CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a report on Thursday, November 5th. Barclays dropped their price target on CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Thursday, November 5th. JPMorgan Chase & Co. boosted their price target on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Finally, Leerink Partners reduced their price objective on CVS Health from $112.00 to $104.00 and set an “outperform” rating on the stock in a research report on Thursday, November 5th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $107.79.

Key CVS Health News

Here’s some of the latest news about CVS:

• Positive Sentiment: CVS’s planned 2028 split could sharpen strategic focus and improve capital allocation, potentially unlocking value in its businesses. Wells Fargo kept an “overweight” rating and sees its $112 price target as implying upside, despite lowering the target from $123. Article: Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
• Neutral Sentiment: Wells Fargo’s price-target cut signals more cautious valuation assumptions, though its continued overweight rating indicates the analyst remains positive on CVS. Article: Wells Fargo rating and price target
• Negative Sentiment: The split is not a guaranteed catalyst: coverage highlights separation costs and execution risks, while Aetna’s recovery and stronger pharmacy profits are weighed against PBM pressures and declining membership. Senator Elizabeth Warren has also criticized the plan, suggesting political scrutiny may continue. Article: Is CVS Stock Worth Buying as Aetna Recovers but PBM Risks Persist?

Insiders Place Their Bets

In other CVS Health news, EVP Prem Shah purchased 23,855 shares of CVS Health stock in a transaction on Friday, November 6th. The shares were bought at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the purchase, the executive vice president directly owned 88,516 shares in the company, valued at $7,425,607.24. This trade represents a 36.89% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.85% of the company’s stock.

CVS Health Price Performance

CVS Health stock opened at $89.69 on Friday. The stock has a market capitalization of $114.76 billion, a P/E ratio of 10.44, a P/E/G ratio of 0.78 and a beta of 0.58. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The firm’s 50-day moving average is $89.81 and its two-hundred day moving average is $89.00.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The company’s revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.60 earnings per share. Equities analysts predict that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.0%. CVS Health’s payout ratio is 30.97%.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.